市场调查报告书
商品编码
1572458
医疗陪伴机器人市场、机会、成长动力、产业趋势分析与预测,2024-2032Healthcare Companion Robots Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032 |
2023 年,全球医疗保健陪伴机器人市场估值为19 亿美元,预计2024 年至2032 年复合年增长率为15.9%。技术快速进步以及需求不断增长为了自动化和便利性。
随着老年人口的不断扩大,人们明显倾向于“就地养老”,而不是搬到机构护理机构。这种转变扩大了对支持个人独立的居家照护解决方案的需求。这些先进的机器人不仅减少了对全职人类照护者的依赖,使家庭照护更加经济,而且透过互动和情感支持缓解孤独和孤立,丰富了老年人的生活。
作为背景,联合国经济和社会事务部报告称,2021年,全球65岁及以上人口约为7.59亿人。这项统计数据强调了全球老年人口的迅速增长,并强调了对客製化解决方案(例如医疗保健伴侣机器人)日益增长的需求。
技术创新透过扩大其功能和应用来推动市场成长。借助人工智慧和机器学习,这些机器人可以解读人类情绪、预见健康问题并进行量身定制的互动。这包括用于流畅对话的自然语言处理和从用户互动中进行自适应学习。此外,当代伴侣机器人拥有先进的感测器,用于监测生命征象、侦测跌倒和观察身体活动。它们与穿戴式医疗设备的整合进一步完善了健康监测和资料准确性。
整个医疗保健陪伴机器人产业根据机器人类型、年龄层、最终用途和地区进行分类。
市场将机器人分为两大类:类动物机器人和类人机器人。人形机器人在市场上占据主导地位,到 2023 年,其估值将达到 14 亿美元。它们通常具有先进的功能,可协助完成日常任务、提供情绪支持并监控健康状况。这种适应性不仅扩大了它们在医疗保健领域的应用,也扩大了它们的市场需求。
该市场按最终用途分为疗养院和老年护理中心、医院和诊所以及家庭医疗保健。值得注意的是,疗养院和老年护理中心领域预计在分析期间复合年增长率为 16%。疗养院和老年护理中心为大量老年人提供服务,其中许多人需要持续的护理和支持。此类设施的集中需求推动了对医疗保健陪伴机器人的需求,帮助完成日常任务、健康监测和提供陪伴。
2023 年,北美医疗保健陪伴机器人产业估值为 7.24 亿美元,预测期内复合年增长率将高达 15%。美国在该地区占据主导地位,正努力应对糖尿病、心臟病和肥胖等慢性病的高发生率。医疗保健伴侣机器人在管理这些状况方面发挥关键作用,提供健康指标监测、用药提醒和日常生活协助等服务。这直接解决了该地区紧迫的医疗保健挑战。此外,北美作为技术创新中心的声誉,加上对先进机器人和人工智慧的重视,推动了医疗保健伴侣机器人的成长。不断推出新的和增强的解决方案凸显了这一势头。
The Global Healthcare Companion Robots Market was valued at USD 1.9 billion in 2023 and is projected to grow at 15.9% CAGR from 2024 to 2032. Key drivers of this growth include an aging population increasingly seeking home assistance, rapid technological advancements, and a rising demand for automation and convenience.
With the expanding elderly demographic, there's a pronounced preference for "aging in place" rather than moving to institutional care facilities. This shift has amplified the demand for home-based care solutions that uphold individual independence. These sophisticated robots not only lessen the dependency on full-time human caregivers, making home care more economical, but also enrich the lives of the elderly by alleviating loneliness and isolation through interactive and emotional support.
For context, the United Nations Department of Economic and Social Affairs reported that in 2021, the global population aged 65 and older was around 759 million. This statistic emphasizes the swift global rise in the elderly population and underscores the growing demand for tailored solutions, such as healthcare companion robots.
Technological innovations are propelling the market growth by broadening their capabilities and applications. With AI and machine learning, these robots can interpret human emotions, foresee health concerns, and engage in tailored interactions. This encompasses natural language processing for fluid conversations and adaptive learning from user interactions. Moreover, contemporary companion robots boast advanced sensors for monitoring vital signs, detecting falls, and observing physical activity. Their integration with wearable medical devices further refines health monitoring and data accuracy.
The overall healthcare companion robots industry is classified based on robot type, age group, end-use, and region.
The market categorizes robots into two types: animal-like and humanoid. Dominating the market, the humanoid segment was valued at USD 1.4 billion in 2023. Designed to closely emulate human interactions, humanoid robots excel in providing companionship and engaging users naturally. Often featuring advanced capabilities, they assist in daily tasks, offer emotional support, and monitor health. This adaptability not only broadens their application in healthcare settings but also amplifies their market demand.
The market is segmented by end-use into nursing homes and elderly care centers, hospitals and clinics, and home healthcare. Notably, the nursing homes and elderly care centers segment is projected to witness a CAGR of 16% during the analysis period. Nursing homes and elderly care centers cater to a significant number of elderly individuals, many of whom need ongoing care and support. This concentrated demand in such facilities propels the need for healthcare companion robots, aiding in daily tasks, health monitoring, and offering companionship.
North America Healthcare Companion Robots Industry was valued at USD 724 million in 2023, with projections indicating a robust CAGR of 15% during the forecast period. The U.S. dominates the region, grappling with a high prevalence of chronic ailments, including diabetes, heart disease, and obesity. Healthcare companion robots play a pivotal role in managing these conditions, offering services like health metric monitoring, medication reminders, and assistance with daily routines. This directly addresses a pressing healthcare challenge in the region. Furthermore, North America's reputation as a technological innovation hub, combined with its emphasis on advanced robotics and AI, propels the growth of healthcare companion robots. The continuous introduction of new and enhanced solutions underscores this momentum.